SHIP1 inhibitor reduces obesity and metabolic dysfunction in mice

Obesity can cause a variety of health complications in affected individuals. Several lines of evidence support an association between chronic inflammation in adipose tissue and obesity complications. In mice, inhibition of a molecule known as SHIP1 reduces immune system activation. However, SHIP1 inhibition has not been explored in the context of obesity.

A new study led by William Kerr of SUNY Upstate Medical University in JCI Insight shows that pharmacological inhibition of SHIP1 improves metabolic phenotypes in mice.

In animals fed a high-fat diet, SHIP1 inhibition prevented excess weight gain and improved .

These beneficial effects of SHIP1 inhibition were the result of reduced inflammation in and an increase in cells types that suppress the immune system.

Together, these results indicate that SHIP1 inhibition should be further explored for control of obesity and diet-related metabolic dysfunction.

Explore further

Loss of inflammatory signaling molecule protects mice against diet-induced obesity

More information: Neetu Srivastava et al, A small-molecule inhibitor of SHIP1 reverses age- and diet-associated obesity and metabolic syndrome, JCI Insight (2016). DOI: 10.1172/jci.insight.88544
Provided by JCI Journals
Citation: SHIP1 inhibitor reduces obesity and metabolic dysfunction in mice (2016, July 21) retrieved 1 July 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors